SCHEMBL6073074

SCHEMBL6073074

CCOC(=O)CN(Cc1cccc(OCCc2ccc(CC)cn2)c1)C(=O)Oc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 12/20 0.46
PPARG P37231 11/20 0.46
LMNA P02545 1/20 0.44
SLC2A1 P11166 3/20 0.43
AR P10275 1/20 0.42
CYP2C9 P11712 6/20 0.42
KCNH2 Q12809 4/20 0.42
SLC2A4 P14672 2/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SLC2A8 Q9NY64 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6072990 0.95 SLC2A1 (0.48) PPARAPPARGLMNASLC2A1CYP2C9
SCHEMBL6073210 0.95 PPARG (0.50) PPARAPPARGLMNASLC2A1CYP2C9
SCHEMBL6073152 0.94 SLC2A1 (0.49) PPARAPPARGLMNASLC2A1AR
SCHEMBL6073095 0.93 PPARG (0.52) PPARAPPARGLMNASLC2A1CYP2C9
SCHEMBL6073162 0.93 PPARA (0.43) PPARAPPARGLMNASLC2A1AR
SCHEMBL6073005 0.92 PPARA (0.49) PPARAPPARGLMNATSHRMAPK1
SCHEMBL6073078 0.92 PPARG (0.45) PPARAPPARGLMNASLC2A1AR
SCHEMBL6073111 0.91 PPARA (0.52) PPARAPPARGSLC2A1CYP2C9KCNH2
SCHEMBL6073085 0.91 LMNA (0.44) PPARAPPARGLMNASLC2A1AR
SCHEMBL6073190 0.90 PPARG (0.41) PPARAPPARGLMNASLC2A1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006117743-A1 SUBSTITUTED AROMATIC COMPOUNDS AS ANTIDIABETIC AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO claimed
WO-2006117743-A1 SUBSTITUTED AROMATIC COMPOUNDS AS ANTIDIABETIC AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed